Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Nucleic Acids Res ; 35(17): 5672-82, 2007.
Article in English | MEDLINE | ID: mdl-17715144

ABSTRACT

Interstrand cross-link (ICL) is a covalent modification of both strands of DNA, which prevents DNA strand separation during transcription and replication. Upon photoactivation 8-methoxypsoralen (8-MOP+UVA) alkylates both strands of DNA duplex at the 5,6-double bond of thymidines, generating monoadducts (MAs) and ICLs. It was thought that bulky DNA lesions such as MAs are eliminated only in the nucleotide excision repair pathway. Instead, non-bulky DNA lesions are substrates for DNA glycosylases and AP endonucleases which initiate the base excision repair (BER) pathway. Here we examined whether BER might be involved in the removal of psoralen-DNA photoadducts. The results show that in human cells DNA glycosylase NEIL1 excises the MAs in duplex DNA, subsequently the apurinic/apyrimidinic endonuclease 1, APE1, removes the 3'-phosphate residue at single-strand break generated by NEIL1. The apparent kinetic parameters suggest that NEIL1 excises MAs with high efficiency. Consistent with these results HeLa cells lacking APE1 and/or NEIL1 become hypersensitive to 8-MOP+UVA exposure. Furthermore, we demonstrate that bacterial homologues of NEIL1, the Fpg and Nei proteins, also excise MAs. New substrate specificity of the Fpg/Nei protein family provides an alternative repair pathway for ICLs and bulky DNA damage.


Subject(s)
DNA Adducts/metabolism , DNA Glycosylases/metabolism , DNA Repair , DNA-(Apurinic or Apyrimidinic Site) Lyase/metabolism , Furocoumarins/metabolism , Cross-Linking Reagents , DNA-Formamidopyrimidine Glycosylase/metabolism , Deoxyribonuclease (Pyrimidine Dimer)/metabolism , Escherichia coli/enzymology , Escherichia coli/genetics , Escherichia coli Proteins/metabolism , HeLa Cells , Humans , Mutation , Oligodeoxyribonucleotides/chemistry , Oligodeoxyribonucleotides/metabolism , Phosphates/metabolism , Ultraviolet Rays
2.
EMBO J ; 24(18): 3235-46, 2005 Sep 21.
Article in English | MEDLINE | ID: mdl-16138080

ABSTRACT

Morphine analgesic properties and side effects such as tolerance are mediated by the mu opioid receptor (MOR) whose endocytosis is considered of primary importance for opioid pharmacological effects. Here, we show that p38 mitogen-activated protein kinase (MAPK) activation is required for MOR endocytosis and sufficient to trigger its constitutive internalization in the absence of agonist. Further studies established a functional link between p38 MAPK and the small GTPase Rab5, a key regulator of endocytosis. Expression of an activated mutant of Rab5 stimulated endocytosis of MOR ligand-independently in wild-type but not in p38alpha-/- cells. We found that p38alpha can phosphorylate the Rab5 effectors EEA1 and Rabenosyn-5 on Thr-1392 and Ser-215, respectively, and these phosphorylation events regulate the recruitment of EEA1 and Rabenosyn-5 to membranes. Moreover, phosphomimetic mutation of Thr-1392 in EEA1 can bypass the requirement for p38alpha in MOR endocytosis. Our results highlight a novel mechanism whereby p38 MAPK regulates receptor endocytosis under physiological conditions via phosphorylation of Rab5 effectors.


Subject(s)
Endocytosis , Membrane Proteins/metabolism , Receptors, Opioid, mu/metabolism , p38 Mitogen-Activated Protein Kinases/metabolism , Animals , Cell Membrane/genetics , Cell Membrane/metabolism , Cells, Cultured , Enzyme Activation , Humans , Membrane Proteins/genetics , Mice , Phosphorylation , Protein Binding , Vesicular Transport Proteins , rab5 GTP-Binding Proteins/genetics , rab5 GTP-Binding Proteins/metabolism
3.
Biochimie ; 87(7): 647-58, 2005 Jul.
Article in English | MEDLINE | ID: mdl-15935541

ABSTRACT

Fanconi anemia (FA) is a recessive cancer prone syndrome featuring bone marrow failure and hypersensitivity to DNA crosslinks. Nine FA genes have been isolated so far. The biochemical function(s) of the FA proteins remain(s) poorly determined. However, a large consensus exists on the evidence that, to cope with DNA cross-links, a cell needs a functional FA pathway. In this review, we resume current understanding of how the FA pathway works in response to DNA damage and how it is integrated in a complex network of proteins involved in the maintenance of the genetic stability.


Subject(s)
Cell Cycle Proteins/metabolism , DNA Damage , DNA-Binding Proteins/metabolism , Fanconi Anemia/genetics , Nuclear Proteins/metabolism , Cell Cycle , DNA Repair , DNA Replication , Fanconi Anemia/metabolism , Fanconi Anemia Complementation Group Proteins , Gene Expression Regulation , Genetic Diseases, Inborn/genetics , Genomic Instability , Humans , Syndrome
4.
Hepatology ; 40(5): 1136-43, 2004 Nov.
Article in English | MEDLINE | ID: mdl-15389866

ABSTRACT

Fas (CD95)-induced hepatocyte apoptosis and cytotoxic activity of neutrophils infiltrating the injured liver are two major events leading to hepatitis. Because it has been reported that opioids, via a direct interaction, sensitize splenocytes to Fas-mediated apoptosis by upregulating Fas messenger RNA (mRNA) and modulated neutrophil activity, we assumed that opioids may participate in the pathophysiology of hepatitis. Using the hepatitis model induced by agonistic anti-Fas antibody in mice, we showed that opioid receptor blockade reduced liver damage and consequently increased the survival rate of animals when the antagonist naltrexone was injected simultaneously or prior to antibody administration. Treatment of mice with morphine enhanced mortality. Naloxone methiodide-a selective peripheral opioid antagonist-had a protective effect, but the absence of opioid receptors in the liver, together with lack of morphine effect in Fas-induced apoptosis of primary cultured hepatocytes, ruled out a direct effect of opioids on hepatocytes. In addition, the neutralization of opioid activity by naltrexone did not modify Fas mRNA expression in the liver as assessed with real-time quantitative polymerase chain reaction. Injured livers were infiltrated by neutrophils, but granulocyte-depleted mice were not protected against the enhancing apoptotic effect of morphine. In conclusion, opioid receptor blockade improves the resistance of mice to Fas-induced hepatitis via a peripheral mechanism that does not involve a down-modulation of Fas mRNA in hepatocytes nor a decrease in proinflammatory activity of neutrophils.


Subject(s)
Hepatitis/etiology , Hepatitis/prevention & control , Naloxone/analogs & derivatives , Narcotic Antagonists , fas Receptor/metabolism , Animals , Antibodies/pharmacology , Cells, Cultured , Female , Hepatitis/mortality , Hepatitis/pathology , Liver/drug effects , Liver/metabolism , Liver/pathology , Mice , Mice, Inbred BALB C , Morphine/pharmacology , Naloxone/pharmacology , Narcotic Antagonists/pharmacology , Narcotics/pharmacology , Quaternary Ammonium Compounds , RNA, Messenger/metabolism , fas Receptor/genetics , fas Receptor/immunology
5.
Mol Cell Biol ; 23(1): 370-81, 2003 Jan.
Article in English | MEDLINE | ID: mdl-12482988

ABSTRACT

p38 mitogen-activated protein (MAP) kinases play an important role in the regulation of cellular responses to all kinds of stresses. The most abundant and broadly expressed p38 MAP kinase is p38alpha, which can also control the proliferation, differentiation, and survival of several cell types. Here we show that the absence of p38alpha correlates with the up-regulation of one of its upstream activators, the MAP kinase kinase MKK6, in p38alpha(-/-) knockout mice and in cultured cells derived from them. In contrast, the expression levels of the p38 activators MKK3 and MKK4 are not affected in p38alpha-deficient cells. The increase in MKK6 protein concentration correlates with increased amounts of MKK6 mRNA in the p38alpha(-/-) cells. Pharmacological inhibition of p38alpha also up-regulates MKK6 mRNA levels in HEK293 cells. Conversely, reintroduction of p38alpha into p38alpha(-/-) cells reduces the levels of MKK6 protein and mRNA to the normal levels found in wild-type cells. Moreover, we show that the MKK6 mRNA is more stable in p38alpha(-/-) cells and that the 3'untranslated region of this mRNA can differentially regulate the stability of the lacZ reporter gene in a p38alpha-dependent manner. Our data indicate that p38alpha can negatively regulate the stability of the MKK6 mRNA and thus control the steady-state concentration of one of its upstream activators.


Subject(s)
Calcium-Calmodulin-Dependent Protein Kinases/genetics , Feedback, Physiological , MAP Kinase Kinase 4 , Mitogen-Activated Protein Kinases/metabolism , RNA Stability , 3' Untranslated Regions , Animals , Base Sequence , Calcium-Calmodulin-Dependent Protein Kinases/metabolism , Cells, Cultured , Cycloheximide/pharmacology , Enzyme Inhibitors/pharmacology , Gene Expression Regulation , Imidazoles/pharmacology , MAP Kinase Kinase 3 , MAP Kinase Kinase 6 , Mice , Mice, Knockout , Mitogen-Activated Protein Kinase Kinases/genetics , Mitogen-Activated Protein Kinase Kinases/metabolism , Mitogen-Activated Protein Kinases/drug effects , Mitogen-Activated Protein Kinases/genetics , Molecular Sequence Data , Myocytes, Cardiac/metabolism , Protein-Tyrosine Kinases/genetics , Protein-Tyrosine Kinases/metabolism , Pyridines/pharmacology , RNA, Messenger/metabolism , Up-Regulation , p38 Mitogen-Activated Protein Kinases
6.
Blood ; 100(9): 3261-8, 2002 Nov 01.
Article in English | MEDLINE | ID: mdl-12384426

ABSTRACT

We previously observed the presence of anti-human mu-opioid-receptor (anti-hMOR) autoantibodies in IgG pools prepared from several thousand healthy blood donors. These autoantibodies behaved agonistically because of their ability to bind to the first and third extracellular loops of the receptor. In this study, we found that each healthy donor's serum contained anti-hMOR IgG autoantibodies with a specific activity against both the first and the third extracellular loops of the receptor. Because of the inability of IgG to cross the blood-brain barrier, we investigated the effects of the expression of anti-hMOR autoantibodies on immune cells. In analogy to studies of the effects of morphine, we investigated the ability of antibodies to sensitize splenocytes to Fas (CD95)-mediated apoptosis. We took advantage of the high sequence homology between murine MOR and hMOR extracellular loops to estimate the effect on murine splenocytes of anti-hMOR antibodies raised by immunizing mice. Splenocytes from mice injected with Chinese hamster ovary (CHO) cells expressing MOR were sensitized to Fas-mediated apoptosis, whereas those from mice injected with CHO cells or phosphate-buffered saline were not. Similar sensitization to Fas-mediated apoptosis was observed in splenocytes from mice undergoing passive transfer either with IgG from mice previously immunized against CHO cells expressing MOR or with IgG directed against the first and third extracellular loops of the receptor. Together, our data show that anti-MOR autoantibodies are commonly expressed in healthy humans and could participate in the control of lymphocyte homeostasis by promoting Fas-mediated apoptosis.


Subject(s)
Apoptosis/immunology , Autoantibodies/blood , Immunoglobulin G/blood , Receptors, Opioid, mu/immunology , Adult , Amino Acid Sequence , Animals , Autoantibodies/physiology , Blood Donors , CHO Cells , Cricetinae , Cricetulus , Female , Homeostasis , Humans , Immunization, Passive , Immunoglobulin G/physiology , Lymphocyte Activation , Mice , Mice, Inbred BALB C , Molecular Sequence Data , Protein Structure, Tertiary , Receptors, Opioid, mu/agonists , Sequence Homology, Amino Acid , Species Specificity , fas Receptor/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...